- Conditions
- Healthy Participants, RFC1 Gene Mutation, Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 10, Spinocerebellar Ataxia Type 2, Spinocerebellar Ataxia Type 27b, Spinocerebellar Ataxia Type 3, Spinocerebellar Ataxia Type 6, Spinocerebellar Ataxia Type 7, Spinocerebellar Ataxia Type 8
- Interventions
- Assessments and Questionnaires, Blood Collection, Cerebrospinal Fluid Collection, Genetic Testing, Magnetic Resonance Imaging (MRI) Scan
- Other · Genetic
- Lead sponsor
- Lauren Moore
- Other
- Eligibility
- 6 Years and older
- Enrollment
- 1,400 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2010 – 2030
- U.S. locations
- 16
- States / cities
- Los Angeles, California • San Francisco, California • Gainesville, Florida + 12 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
The live registry is temporarily unavailable. These stored records may be incomplete or out of date. Check the official record for current status and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1249–1272
of 5,091
matching trials from the local directory fallback.
- Conditions
- Addiction, Cardiometabolic Health Indicators, Eating Disorders, Mental Health, Obesity & Overweight
- Interventions
- GLP-1 Receptor Agonist Therapy, Structured Lifestyle Intervention
- Drug · Behavioral
- Lead sponsor
- Texas Tech University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 27 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- Lubbock, Texas
- Conditions
- Urea Cycle Disorder
- Interventions
- Not listed
- Lead sponsor
- St. Jude Children's Research Hospital
- Other
- Eligibility
- 16 Years to 40 Years
- Enrollment
- 60 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2032
- U.S. locations
- 1
- States / cities
- Memphis, Tennessee
- Conditions
- Aging, Behavior Change, Cognitive Ability, Physical Inactivity
- Interventions
- Text Messaging Intervention
- Behavioral
- Lead sponsor
- University of Michigan
- Other
- Eligibility
- 40 Years and older
- Enrollment
- 150 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2027
- U.S. locations
- 1
- States / cities
- Ann Arbor, Michigan
- Conditions
- Cervical Carcinoma, Human Papillomavirus Infection
- Interventions
- Biospecimen Collection, Cervical Biopsy, Colposcopy, Electronic Health Record Review, Endocervical Curettage, Excision, HPV Self-Collection, Human Papillomavirus Test, Questionnaire Administration
- Procedure · Other
- Lead sponsor
- National Cancer Institute (NCI)
- NIH
- Eligibility
- 25 Years and older · Female only
- Enrollment
- 500 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2027
- U.S. locations
- 18
- States / cities
- Birmingham, Alabama • Atlanta, Georgia • Lafayette, Louisiana + 12 more
- Conditions
- Stakeholder Engagement
- Interventions
- Toolkit
- Behavioral
- Lead sponsor
- NYU Langone Health
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 480 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Thrombosis
- Interventions
- Not listed
- Lead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- NIH
- Eligibility
- 18 Years to 100 Years
- Enrollment
- 400 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2041
- U.S. locations
- 1
- States / cities
- Bethesda, Maryland
- Conditions
- Aortic Diseases, Atrial Fibrillation, Cardiovascular Diseases, Congenital Heart Disease, Heart Failure, Ischemic Heart Disease, Metabolic Cardiomyopathy, Non-ischemic Cardiomyopathy, Valvular Heart Disease, Ventricular Fibrillation
- Interventions
- Not listed
- Lead sponsor
- The Cleveland Clinic
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 1,000 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2037
- U.S. locations
- 1
- States / cities
- Cleveland, Ohio
- Conditions
- Cardiometabolic Health Indicators, Whole-body Antioxidant Capacity
- Interventions
- Sweetened placebo beverage +liquid meal test at baseline, Watermelon Juice + liquid meal test at baseline
- Other
- Lead sponsor
- University of California, Los Angeles
- Other
- Eligibility
- Female only
- Enrollment
- 22 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2027
- U.S. locations
- 1
- States / cities
- Los Angeles, California
- Conditions
- Nicotine Vaping
- Interventions
- Kick-Nic! mobile phone application, NCI Quit Vaping website
- Behavioral
- Lead sponsor
- Yale University
- Other
- Eligibility
- 12 Years to 19 Years
- Enrollment
- 306 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2029
- U.S. locations
- 1
- States / cities
- New Haven, Connecticut
- Conditions
- Aging
- Interventions
- Transcranial direct current stimulation
- Device
- Lead sponsor
- University of Florida
- Other
- Eligibility
- 65 Years to 89 Years
- Enrollment
- 60 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2030
- U.S. locations
- 1
- States / cities
- Gainesville, Florida
- Conditions
- Poor Sleep Quality
- Interventions
- HCHS consumption, Walnut consumption
- Other
- Lead sponsor
- Columbia University
- Other
- Eligibility
- 45 Years to 65 Years
- Enrollment
- 24 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2026
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Liver Fibrosis, Metabolic Dysfunction-Associated Steatohepatitis (MASH), Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD), Non-Alcoholic Fatty Liver Disease, Obesity
- Interventions
- Incretin-Based Therapy, Metabolic surgery
- Drug · Procedure
- Lead sponsor
- The Cleveland Clinic
- Other
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 120 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2029
- U.S. locations
- 4
- States / cities
- Phoenix, Arizona • Indianapolis, Indiana • Rochester, Minnesota + 1 more
- Conditions
- Implementation Science, Informed Consent, Neonatal Screening
- Interventions
- Educational Website and Video
- Behavioral
- Lead sponsor
- Erin Rothwell
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 5,980 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2028
- U.S. locations
- 2
- States / cities
- Salt Lake City, Utah
- Conditions
- Systemic Lupus Erythematosus (Sle)
- Interventions
- Nicotinamide Riboside
- Dietary Supplement
- Lead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- NIH
- Eligibility
- 18 Years to 120 Years · Female only
- Enrollment
- 78 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2028
- U.S. locations
- 1
- States / cities
- Bethesda, Maryland
- Conditions
- Center Involved Diabetic Macular Edema, Diabetic Macular Edema
- Interventions
- OCU200
- Drug
- Lead sponsor
- Ocugen
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 24 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2026
- U.S. locations
- 5
- States / cities
- Deerfield Beach, Florida • Erie, Pennsylvania • Bellaire, Texas + 2 more
- Conditions
- Breast Cancer
- Interventions
- Dual-Energy Contrast-Enhanced Spectral Mammography (CESM)
- Diagnostic Test
- Lead sponsor
- American College of Radiology
- Other
- Eligibility
- 45 Years to 74 Years · Female only
- Enrollment
- 2,032 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2027
- U.S. locations
- 12
- States / cities
- Birmingham, Alabama • Boca Raton, Florida • The Villages, Florida + 9 more
- Conditions
- Anxiety Disorders and Symptoms, Depressive Symptoms
- Interventions
- Space for depression, Space for resilience, The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP)
- Behavioral
- Lead sponsor
- Boston University Charles River Campus
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 1,800 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2027
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Vision Impairment
- Interventions
- Not listed
- Lead sponsor
- Vanderbilt University
- Other
- Eligibility
- 3 Years to 21 Years
- Enrollment
- 795 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2001 – 2028
- U.S. locations
- 1
- States / cities
- Nashville, Tennessee
- Conditions
- Dry Eye
- Interventions
- Tyrvaya
- Drug
- Lead sponsor
- Ocular Aesthetics, LLC dba Ocular Clinical Trials
- Other
- Eligibility
- 18 Years to 99 Years
- Enrollment
- 50 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2027
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Elbow Fractures
- Interventions
- Buzzy Ice pack, Flash Cards
- Device · Other
- Lead sponsor
- University of Oklahoma
- Other
- Eligibility
- 3 Years to 10 Years
- Enrollment
- 75 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2027
- U.S. locations
- 2
- States / cities
- Oklahoma City, Oklahoma
- Conditions
- JOURNAVX, Multimodal Analgesia, Nav 1.8, Opioid Cessation, Opioid Consumption, Postoperative, Pain, Pain Management, Randomized Controlled Study, Randomized Controlled Trial, Randomized Controlled Trials, Suzetrigine, Total Hip Arthroplasty (THA), Total Hip Arthroplasty \(THA\), Total Hip Replacement, Total Hip Replacement Arthroplasty, Total Hip Replacement Surgery, Total Hip Replacements
- Interventions
- Placebo, Suzetrigine
- Other · Drug
- Lead sponsor
- Hospital for Special Surgery, New York
- Other
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 210 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2028
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Fontan Circulation, Single-ventricle
- Interventions
- Lower extremity compression garments, Without compression garments
- Device · Other
- Lead sponsor
- University of Texas Southwestern Medical Center
- Other
- Eligibility
- 18 Years to 45 Years
- Enrollment
- 20 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2027
- U.S. locations
- 1
- States / cities
- Dallas, Texas
- Conditions
- HPV Positive Oropharyngeal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma, Locally Advanced, New Diagnosis Tumor
- Interventions
- CUE-101, Pembrolizumab
- Drug
- Lead sponsor
- Yale University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 30 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2031
- U.S. locations
- 1
- States / cities
- New Haven, Connecticut